Howe & Rusling Inc Gilead Sciences, Inc. Transaction History

Howe & Rusling Inc

$1.16 Billion
Q4 2024

A detailed history of Howe & Rusling Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Howe & Rusling Inc holds 4,704 shares of GILD stock, worth $485,970. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,704

Previous 4,589 2.51%

Holding current value

$485,970

Previous $384,000 13.02%

% of portfolio

0.04%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$83.95 - $97.9 $9,654 - $11,258	115 Added 2.51%	4,704 $434,000
Q3 2024 Nov 08, 2024	SELL	$66.59 - $83.99 $1,997 - $2,519	-30 Reduced 0.65%	4,589 $384,000
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $17,429 - $20,114	-276 Reduced 5.64%	4,619 $316,000
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $4,652 - $5,673	65 Added 1.35%	4,895 $358,000
Q4 2023 Feb 05, 2024	BUY	$73.27 - $83.09 $5,641 - $6,397	77 Added 1.62%	4,830 $391,000
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $3,844 - $4,194	52 Added 1.11%	4,753 $356,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $7,753 - $8,843	102 Added 2.22%	4,701 $362,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $154 - $176	-2 Reduced 0.04%	4,599 $381,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $13,087 - $18,788	-210 Reduced 4.36%	4,601 $394,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $2,917 - $3,332	49 Added 1.03%	4,811 $297,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $9,523 - $10,726	165 Added 3.59%	4,762 $294,000
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $5,907 - $7,403	102 Added 2.27%	4,597 $273,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $64 - $73	-1 Reduced 0.02%	4,495 $326,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $67 - $73	1 Added 0.02%	4,496 $314,000
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $600 - $684	10 Added 0.22%	4,495 $291,000
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $2,421 - $3,045	-39 Reduced 0.86%	4,485 $283,000
Q2 2020 Jul 15, 2020	SELL	$72.34 - $84.0 $42,752 - $49,644	-591 Reduced 11.55%	4,524 $348,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $12,713 - $16,284	-203 Reduced 3.82%	5,115 $382,000
Q3 2019 Oct 31, 2019	SELL	$62.51 - $69.0 $1,625 - $1,794	-26 Reduced 0.49%	5,318 $337,000
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $8,352 - $9,366	-135 Reduced 2.46%	5,344 $361,000
Q1 2019 Apr 29, 2019	SELL	$62.53 - $70.05 $49,336 - $55,269	-789 Reduced 12.59%	5,479 $356,000
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $363 - $474	-6 Reduced 0.1%	6,268 $392,000
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $41,977 - $48,964	-647 Reduced 9.35%	6,274 $444,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $478,413 - $583,238	-6,568 Reduced 48.69%	6,921 $522,000
Q4 2017 Jan 24, 2018	SELL	$71.15 - $83.52 $257,207 - $301,924	-3,615 Reduced 21.14%	13,489 $966,000
Q3 2017 Oct 18, 2017	BUY	$72.11 - $85.47 $1.23 Million - $1.46 Million	17,104	17,104 $1.39 Million

Others Institutions Holding GILD

# of Institutions

2,030

Shares Held

1.01B

Call Options Held

10M

Put Options Held

8.9M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $129B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Account